Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2026-05-21 @ 11:57 PM
Study NCT ID:
NCT05667493
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-12-12
First Post:
2022-07-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization: